Sitemap
Japanese
Blue skies, blue oceans, beautiful earth...
Let us preserve this wonderful earth for ever.
Invaluable life...
Let us always keep our respect for life.
The treasure of a society is people.
Let us value our spirit, which makes us humane.
2012/05/06
Press Release :
SNBL USA Demonstrates GLP Compliant Capabilities
2012/04/04
Press Release :
Results of First Phase I Clinical Study for Intranasal Zolmitriptan Formulation (Migraine Drug)
2012/02/09
Site establishment guidance
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD NDS DIVISION
2011/08/19
Press Release :
Initiation of US Phase I Clinical Study of Intranasal Zolmitriptan for Migraine
2011/06/10
Press Release :
US FDA's New View on Development of Intranasal Granisetron
- Simplified Clinical Development Requirements Will Quicken NDA Submission -
2011/03/30
Press Release :
Conclusion of agreement to develop pilocarpine hydrochloride for treatment of fibromyalgia
2011/02/10
Press Release :
Conclusion of Licensing Agreement with Pastorus Pharma, LLC.
2010/08/19
Press Release :
Results of a Meeting with the US Food and Drug Administration (FDA) Concerning the Development of Intranasal Granisetron
Planning for a Phase 3 Study to Improve Patient Quality of Life (QOL)
2010/08/11
Press Release :
Intranasal Zolmitriptan: Clinical Study of Rapid Acting Migraine Drug
-Preparations Underway for US Phase 1 Clinical Study-
2010/05/12
Press Release :
Research Progress on TR-Flu, an Intranasal Flu Vaccine in Dry Powder Form
(First Report)
2009/09/03
Press Release :
Development of Nasal Zolmitriptan Product for Migraine
2009/08/03
Press Release :
First Report on Results of US Phase 2 Clinical Study of Intranasal Granisetron
2008/02/18
Press Release :
Results of Phase I Clinical Trial for Intranasal Granisetron Formulation (First Report)
2006/07/27
Press Release :
Translational Research, Ltd. (subsidiary company) completes the agreement to license out nasal drug delivery technology.
2005/11/24
Press Release :
Translational Research, Ltd. (subsidiary company) signs a general terms sheet for the license transfer of a nasal drug delivery technolgy, and Bioactis, Ltd. (subsidiary company) signs a general terms sheet for device supply agreement.
